International

Sputnik Lite has proven to be ‘ideal booster’ for other vaccines: Russian Direct Investment Fund

MOSCOW: The coronavirus vaccine Sputnik Lite has proven to be an ideal booster for other vaccines and is ready to fight COVID-19 globally, the Russian Direct Investment Fund said on Thursday (October 7).

stating his readiness to fight COVID-19 Globally, the Russian firm has said that the one-shot Sputnik Light has proven to be an ideal booster for other vaccines.

The official Twitter handle of Sputnik V said in a tweet: “More studies are expected this month to show the benefits of Mix & Match Boosting, which was started 1.5 years ago by #SputnikV. Its first ingredient, 1-shot Sputnik Lite, has been proven to be an ideal booster for other vaccines and is poised to fight #COVID globally.”

The Sputnik Lite vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. Sputnik Light has proved effective against all new strains of coronavirusAs demonstrated by the Gamleya Center during laboratory tests and is compatible with standard vaccine storage and logistics requirements, the Russian Direct Investment Fund (RDIF) said in a statement.

According to the RDIF, the Sputnik Lite vaccine is based on a well-studied human adenoviral vector platform, which has been proven to be safe and effective without any long-term side effects, as evidenced by more than 250 clinical trials conducted globally over the past two decades. Confirmed in tests. .

By Naveen Bharat Staff

 

Back to top button